関連する実験動画
Updated: Feb 20, 2026

09:12
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
3.3K
人口統計的要因と胆性アトレシア:小児性肝疾患研究ネットワークの研究
Zachary J Kastenberg1, Charlotte A Beil2, Lisa Henn2
1Department of Surgery, Division of Pediatric Surgery, Intermountain Primary Children's Hospital, University of Utah, Salt Lake City, Utah.
Pediatrics
|February 18, 2026
まとめ
コミュニティの貧困,人種,民族性は,肝臓・腸内静脈外科手術の割合が低く,胆道不動症の乳児の手術が遅れていることと関連しています. これらの要因は,臨床的変数とともに,手術の成功と本来の肝臓の生存に影響を与えます.
科学分野:
- 小児外科手術について
- 肝臓病理学 肝臓病理学
- 公衆衛生は公衆衛生である.
背景:
- 胆管不動症は,新生児の重度の肝疾患であり,手術の迅速な介入が必要である.
- 社会経済的および人種的格差は,小児性肝疾患の治療へのアクセスと治療結果に影響を与える可能性があります.
- ヘパトポルトエンテロストミーは,胆管不全の主要な外科治療である.
研究 の 目的:
- 地域社会における貧困,人種,民族との関連性,および肝臓・腸管切除手術を受ける可能性の関連性を調査する.
- 胆道不動症の手術時の年齢に対するこれらの人口学的要因の影響を調べる.
- 人口統計学的,臨床的,または解剖学的変数が,胆管不全の乳児における手術の成功と本来の肝臓の生存に影響するかどうかを決定する.
主な方法:
- 幼児肝疾患研究ネットワーク (ChiLDReN) の胆道不動症の乳児の将来的に登録されたコホートの分析.
- 米国の人口統計を反映した719人の乳児の含有.
- 線形回帰とロジスティック回帰を用いて,変数と手術結果の関連性を検証する.
主要な成果:
- コミュニティの貧困,アジア系人種,ヒスパニック系民族は,肝臓移植腸切除手術を受ける可能性の低下と関連していました.
- 地域社会における貧困の増大は,肝臓・腸内静止術の後の年齢と相関する.
- 黒人/アフリカ系アメリカ人の乳児は,白人の乳児と比較して,手術時の年齢がかなり高かった.
結論:
- コミュニティの貧困,人種,民族性は,胆道不動症の乳児における肝門腸口切除の割合とタイミングに大きく影響します.
- 臨床的および解剖学的要因は,成功した胆汁排水とネイティブ肝臓の生存とより強く関連しています.
- 社会経済的および人種的格差の解決は,小児性肝疾患の改善に不可欠です.
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
213
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
344
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258

